British pharmaceutical firm GlaxoSmithKline’s deal to manufacture the Novavax Covid-19 vaccine will help shore up local supply. Photo: Reuters
GlaxoSmithKline to manufacture Novavax Covid-19 vaccine in UK
  • The agreement has the potential to reduce the UK’s reliance on overseas vaccine supplies amid a dispute with the EU over exports
  • PM Boris Johnson said Britain is building up its long-term manufacturing capabilities, and is on track to offer a first vaccine dose to all adults by late July
30 Mar 2021 - 2:00PM